Ventas, Inc. $VTR Stake Boosted by Amundi

Key Points

• Amundi increased its Ventas stake by 7.3% in the second quarter, owning 1.78 million shares worth approximately $158.3 million. Institutional investors collectively hold 94.18% of the healthcare REIT’s stock.
• Analysts remain broadly positive, with 14 Buy ratings and three Holds, producing a “Moderate Buy” consensus and an average price target of $99, above the reported share price of $89.94.
• Ventas exceeded quarterly expectations with adjusted earnings of $0.97 per share and revenue of $1.73 billion, while revenue increased 21.7% year over year.

Amundi lifted its stake in shares of Ventas, Inc. (NYSE:VTR - Free Report) by 7.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,782,345 shares of the real estate investment trust's stock after purchasing an additional 121,816 shares during the quarter. Amundi owned about 0.35% of Ventas worth $158,272,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. Advus Financial Partners LLC lifted its stake in Ventas by 17.2% in the second quarter. Advus Financial Partners LLC now owns 4,932 shares of the real estate investment trust's stock valued at $438,000 after buying an additional 725 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Ventas during the second quarter worth about $17,244,000. California State Teachers Retirement System increased its holdings in shares of Ventas by 9,549.4% in the 2nd quarter. California State Teachers Retirement System now owns 65,366,390 shares of the real estate investment trust's stock worth $5,804,535,000 after acquiring an additional 64,688,974 shares during the period. Readystate Asset Management LP acquired a new stake in shares of Ventas in the 2nd quarter worth about $1,814,000. Finally, Ameritas Advisory Services LLC bought a new stake in Ventas in the 2nd quarter valued at about $57,000. Institutional investors own 94.18% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Jefferies Financial Group boosted their target price on shares of Ventas from $97.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, May 12th. Wells Fargo & Company raised their price target on shares of Ventas from $96.00 to $104.00 and gave the company an "overweight" rating in a research note on Tuesday, September 1st. Weiss Ratings upgraded Ventas from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Tuesday, July 21st. Scotiabank boosted their price objective on Ventas from $93.00 to $95.00 and gave the stock a "sector perform" rating in a research report on Wednesday, September 2nd. Finally, Barclays increased their price objective on Ventas from $99.00 to $102.00 and gave the stock an "equal weight" rating in a report on Monday, August 31st. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $99.00.

Ventas Stock Down 0.4%

Ventas stock opened at $89.94 on Wednesday. Ventas, Inc. has a 52 week low of $66.54 and a 52 week high of $101.60. The stock has a market cap of $46.13 billion, a price-to-earnings ratio of 166.55, a PEG ratio of 3.52 and a beta of 0.70. The company's 50-day moving average price is $92.99 and its two-hundred day moving average price is $87.89. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86.

Ventas (NYSE:VTR - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the business posted $0.87 EPS. The business's revenue for the quarter was up 21.7% compared to the same quarter last year. On average, analysts expect that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Ventas Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.